Phathom Pharmaceuticals, Inc. Net Income Loss

• Phathom Pharmaceuticals, Inc. showed an increase of +33.8% in Net Income Loss from 2024 to 2025.
• This data is from Phathom Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), Phathom Pharmaceuticals, Inc.'s Net Income Loss has declined by 17,077.6%.
• Historical annual values: Fiscal year 2025: -$221.25 million | Fiscal year 2024: -$334.33 million | Fiscal year 2023: -$201.59 million | Fiscal year 2022: -$197.72 million | Fiscal year 2021: -$143.88 million | Fiscal year 2020: -$129.07 million | Fiscal year 2019: -$255.13 million | Fiscal year 2018: -$1.29 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026